Acrivon Therapeutics
ACRV
ACRV
48 hedge funds and large institutions have $44.9M invested in Acrivon Therapeutics in 2025 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 47 → 48 (+1)
Holders
48
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.06M | |
| 2 | +$753K | |
| 3 | +$578K | |
| 4 |
Two Sigma Advisers
New York
|
+$429K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$219K |
Top Sellers
| 1 | -$988K | |
| 2 | -$728K | |
| 3 | -$274K | |
| 4 |
Squarepoint
New York
|
-$170K |
| 5 |
Millennium Management
New York
|
-$138K |
